Kelley C. O’Donnell

2.5k total citations
24 papers, 1.1k citations indexed

About

Kelley C. O’Donnell is a scholar working on Cellular and Molecular Neuroscience, Clinical Psychology and Organic Chemistry. According to data from OpenAlex, Kelley C. O’Donnell has authored 24 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Cellular and Molecular Neuroscience, 11 papers in Clinical Psychology and 7 papers in Organic Chemistry. Recurrent topics in Kelley C. O’Donnell's work include Psychedelics and Drug Studies (11 papers), Chemical synthesis and alkaloids (7 papers) and Neurotransmitter Receptor Influence on Behavior (5 papers). Kelley C. O’Donnell is often cited by papers focused on Psychedelics and Drug Studies (11 papers), Chemical synthesis and alkaloids (7 papers) and Neurotransmitter Receptor Influence on Behavior (5 papers). Kelley C. O’Donnell collaborates with scholars based in United States, Czechia and Chile. Kelley C. O’Donnell's co-authors include Todd D. Gould, Alvaro Sagasti, Husseini K. Manji, Eliot R. Dow, Mauricio E. Vargas, Mark Stahl, Aaron Lulla, Jeff M. Bronstein, Robert J. Schloesser and Haim Einat and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Neuroscience and American Journal of Psychiatry.

In The Last Decade

Kelley C. O’Donnell

23 papers receiving 1.1k citations

Peers

Countries citing papers authored by Kelley C. O’Donnell

Since Specialization

Citations

This map shows the geographic impact of Kelley C. O’Donnell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kelley C. O’Donnell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kelley C. O’Donnell more than expected).

Fields of papers citing papers by Kelley C. O’Donnell

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kelley C. O’Donnell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kelley C. O’Donnell. The network helps show where Kelley C. O’Donnell may publish in the future.

Co-authorship network of co-authors of Kelley C. O’Donnell

This figure shows the co-authorship network connecting the top 25 collaborators of Kelley C. O’Donnell. A scholar is included among the top collaborators of Kelley C. O’Donnell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kelley C. O’Donnell. Kelley C. O’Donnell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Relationality and Ethics in MDMA-Assisted Therapy 2025 ·The American Journal of Bioethics ·(unknown), (unknown), Chantelle Thomas, Ingmar Gorman, Kelley C. O’Donnell	0
2	Psychedelic medicine in psychiatry residency training: a survey of psychiatric residency program directors 2024 ·International Review of Psychiatry ·(unknown), Terence H. W. Ching, Noam Goldway, (unknown), (unknown), Natalie Gukasyan, Christopher Pittenger, Benjamin Kelmendi, Stephen Ross, G Glick, Kelley C. O’Donnell	1
3	The conceptual framework for the therapeutic approach used in phase 3 trials of MDMA-assisted therapy for PTSD 2024 ·Frontiers in Psychology ·Kelley C. O’Donnell, (unknown), (unknown), Christopher R. Nicholas, Chantelle Thomas, (unknown), Ann T. Mithoefer, Michael C. Mithoefer, Marcela Ot’alora G.	11
4	What Is in a Name? The Many Meanings of “Psychedelic” 2023 ·PubMed ·Kelley C. O’Donnell, (unknown), Terence H. W. Ching, G Glick, Noam Goldway, Natalie Gukasyan, (unknown), Benjamin Kelmendi, Stephen Ross, (unknown), Christopher Pittenger	5
5	The conundrum of therapeutic intoxication 2022 ·The British Journal of Psychiatry ·David S. Mathai, David B. Yaden, Kelley C. O’Donnell	4
6	Psilocybin for alcohol use disorder: Rationale and design considerations for a randomized controlled trial 2022 ·Contemporary Clinical Trials ·Kelley C. O’Donnell, Sarah E. Mennenga, Lindsey T. Owens, Samantha K. Podrebarac, (unknown), John Rotrosen, Stephen Ross, Alyssa A. Forcehimes, Michael P. Bogenschutz	15
7	Spiritual experiences in psychedelic-assisted psychotherapy: Case reports of communion with the divine, the departed, and saints in research using psilocybin for the treatment of alcohol dependence. 2021 ·Spirituality in Clinical Practice ·Samantha K. Podrebarac, Kelley C. O’Donnell, Sarah E. Mennenga, Lindsey T. Owens, (unknown), (unknown), Michael P. Bogenschutz	16
8	Psilocybin for depression: Considerations for clinical trial design 2019 ·Kelley C. O’Donnell, Sarah E. Mennenga, Michael P. Bogenschutz	10
9	Neurotoxicity of the Parkinson Disease-Associated Pesticide Ziram Is Synuclein-Dependent in Zebrafish Embryos 2016 ·Environmental Health Perspectives ·Aaron Lulla, Lisa M. Barnhill, Gal Bitan, Magdalena I. Ivanova, Binh P. Nguyen, Kelley C. O’Donnell, Mark Stahl, (unknown), F.-G. Klarner, Thomas Schräder, Alvaro Sagasti, Jeff M. Bronstein	62
10	Axon degeneration and PGC1α-mediated protection in a vertebrate model of α-synuclein toxicity 2014 ·Disease Models & Mechanisms ·Kelley C. O’Donnell, Aaron Lulla, Mark Stahl, (unknown), Jeff M. Bronstein, Alvaro Sagasti	72
11	WldS and PGC-1α Regulate Mitochondrial Transport and Oxidation State after Axonal Injury 2013 ·Journal of Neuroscience ·Kelley C. O’Donnell, Mauricio E. Vargas, Alvaro Sagasti	84
12	Aldehyde dehydrogenase inhibition as a pathogenic mechanism in Parkinson disease 2012 ·Proceedings of the National Academy of Sciences ·Arthur G. Fitzmaurice, Shannon Rhodes, Aaron Lulla, Niall Murphy, Hoa A. Lam, Kelley C. O’Donnell, Lisa M. Barnhill, John E. Casida, Myles Cockburn, Alvaro Sagasti, Mark Stahl, Nigel T. Maidment, Beate Ritz, Jeff M. Bronstein	152
13	Dynamics of degeneration and regeneration in developing zebrafish peripheral axons reveals a requirement for extrinsic cell types 2012 ·Neural Development ·(unknown), (unknown), Kelley C. O’Donnell, (unknown), Alvaro Sagasti, Miguel L. Allende	55
14	Antidepressant-like responses to lithium in genetically diverse mouse strains 2011 ·Genes Brain & Behavior ·Ayşe Can, (unknown), Sean C. Piantadosi, David Dao, Kelley C. O’Donnell, Todd D. Gould	58
15	Generation and behavioral characterization of β-catenin forebrain-specific conditional knock-out mice 2008 ·Behavioural Brain Research ·Todd D. Gould, Kelley C. O’Donnell, (unknown), Eliot R. Dow, Guang Chen, Husseini K. Manji	64
16	β-Catenin Overexpression in the Mouse Brain Phenocopies Lithium-Sensitive Behaviors 2007 ·Neuropsychopharmacology ·Todd D. Gould, Haim Einat, Kelley C. O’Donnell, (unknown), Robert J. Schloesser, Husseini K. Manji	119
17	Involvement of AMPA receptors in the antidepressant-like effects of lithium in the mouse tail suspension test and forced swim test 2007 ·Neuropharmacology ·Todd D. Gould, Kelley C. O’Donnell, Eliot R. Dow, Jing Du, Guang Chen, Husseini K. Manji	92
18	Targeting Signal Transduction Pathways in the Treatment of Mood Disorders: Recent Insights into the Relevance of the Wnt Pathway 2007 ·CNS & Neurological Disorders - Drug Targets ·Todd D. Gould, Eliot R. Dow, Kelley C. O’Donnell, Guang Chen, Husseini K. Manji	24
19	The behavioral actions of lithium in rodent models: Leads to develop novel therapeutics 2007 ·Neuroscience & Biobehavioral Reviews ·Kelley C. O’Donnell, Todd D. Gould	109
20	Strain Differences in Lithium Attenuation of d-Amphetamine-Induced Hyperlocomotion: A Mouse Model for the Genetics of Clinical Response to Lithium 2006 ·Neuropsychopharmacology ·Todd D. Gould, Kelley C. O’Donnell, (unknown), Husseini K. Manji	92

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact